Allergan Seeks To Block Pfizer Unit's Generic Dry-Eye Drug
By Kali Hays ( September 15, 2015, 5:50 PM EDT) -- Allergan Inc. has hit InnoPharma Inc. with a patent-infringement lawsuit in Delaware federal court seeking to block the Pfizer Inc.-owned drugmaker from releasing a generic version of Allergan's chronic dry-eye drug Restasis....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.